The Enterprise Value as of November 2024 (TTM) for Assertio Holdings, Inc. (ASRT) is 96.49M

According to Assertio Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 96.49M. This represents a change of -3.05% compared to the average of 99.52M of the last 4 quarters.

Assertio Holdings, Inc. (ASRT) Historical Enterprise Value (quarterly & annually)

How has ASRT Enterprise Value performed in the past?

The mean historical Enterprise Value of Assertio Holdings, Inc. over the last ten years is 652.90M. The current 96.49M Enterprise Value has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), ASRT's Enterprise Value was at its highest in in the September 2016 quarter at 2.11B. The Enterprise Value was at its lowest in in the March 2020 quarter at 4.62M.

Assertio Holdings, Inc. (ASRT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Assertio Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Assertio Holdings, Inc. (ASRT) Average Enterprise Value

How has ASRT Enterprise Value performed in the past?

The current Enterprise Value of Assertio Holdings, Inc. (ASRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Assertio Holdings, Inc. (ASRT) Enterprise Value vs. Peers

How is ASRT’s Enterprise Value compared to its peers?

Assertio Holdings, Inc.’s Enterprise Value is greater than Agile Therapeutics, Inc. (7.87M), less than Amneal Pharmaceuticals, Inc. (5.29B), greater than AcelRx Pharmaceuticals, Inc. (1.19M), less than Lifecore Biomedical, Inc. (343.37M), less than Ironwood Pharmaceuticals, Inc. (1.20B), less than Neurocrine Biosciences, Inc. (12.10B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Esperion Therapeutics, Inc. (760.76M), less than ANI Pharmaceuticals, Inc. (1.26B), less than Alkermes plc (4.21B), less than Dr. Reddy's Laboratories Limited (5.23T), less than Collegium Pharmaceutical, Inc. (1.45B), less than Pacira BioSciences, Inc. (1.17B), less than Intra-Cellular Therapies, Inc. (8.71B), less than Catalent, Inc. (15.33B), less than Amphastar Pharmaceuticals, Inc. (2.91B), less than Alvotech (5.07B), greater than Eagle Pharmaceuticals, Inc. (16.86M), less than Evolus, Inc. (1.06B),

Build a custom stock screener for Assertio Holdings, Inc. (ASRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assertio Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Assertio Holdings, Inc. (ASRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Assertio Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.